Opsidio
Bryn Mawr
About Opsidio
A biotech company, engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases. The company was founded in 2012 and is headquartered in Bryn Mawr, Pennsylvania .
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $500.0K
- Last round: Series Unknown (Sep 2017)
- Website: opsidio.com
- Phone: (484) 557-0698
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/opsidio-9878 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.